Singapore markets open in 5 hours 43 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,302.37 +55.69 (+1.06%) Dow
39,848.70 +290.59 (+0.73%) Nasdaq
16,737.76 +226.58 (+1.37%) Bitcoin USD
65,661.58 +4,244.54 (+6.91%) CMC Crypto 200
1,385.87 +117.92 (+9.30%)
GILD Jan 2025 67.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:58PM EDT. Market open.
| Previous close | 5.15 |
| Open | 5.07 |
| Bid | 5.05 |
| Ask | 5.25 |
| Strike | 67.50 |
| Expiry date | 2025-01-17 |
| Day's range | 4.97 - 5.07 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.43k |
Business WireKite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.